{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:21:24Z","timestamp":1740144084766,"version":"3.37.3"},"reference-count":44,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T00:00:00Z","timestamp":1556323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["3P05A07825"],"award-info":[{"award-number":["3P05A07825"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00005-019-00542-9","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T08:01:53Z","timestamp":1556352113000},"page":"237-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response"],"prefix":"10.2478","volume":"67","author":[{"given":"Ma\u0142gorzata","family":"Miesza\u0142a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold J.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Drab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-6591","authenticated-orcid":false,"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2019,4,27]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1128\/IAI.70.3.1293-1300.2002","volume":"70","author":"SR Andersen","year":"2002","unstructured":"Andersen SR, Guthrie T, Guile GR et al (2002) Cross-reactive polyclonal antibodies to the inner core of lipopolysaccharide from Neisseria meningitidis. Infect Immun 70:1293\u20131300","journal-title":"Infect Immun"},{"key":"542_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/infdis\/159.2.195","volume":"159","author":"P Brandtzaeg","year":"1989","unstructured":"Brandtzaeg P, Kierulf P, Gaustad P et al (1989) Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis 159:195\u2013204","journal-title":"J Infect Dis"},{"key":"542_CR3","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1016\/j.vaccine.2005.06.011","volume":"23","author":"AD Cox","year":"2005","unstructured":"Cox AD, Zou W, Gidney MA et al (2005) Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits. Vaccine 23:5045\u20135054","journal-title":"Vaccine"},{"key":"542_CR4","doi-asserted-by":"publisher","first-page":"7175","DOI":"10.1073\/pnas.88.16.7175","volume":"88","author":"SJ Devi","year":"1991","unstructured":"Devi SJ, Robbins JB, Schneerson R (1991) Antibodies to poly[(2-8)-alpha-N-acetylneuraminic acid] and poly[(2-9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1. Proc Natl Acad Sci USA 88:7175\u20137179","journal-title":"Proc Natl Acad Sci USA"},{"key":"542_CR5","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.tibtech.2018.03.002","volume":"36","author":"M Drab","year":"2018","unstructured":"Drab M (2018) Phage aggregation-dispersion by ions: striving beyond antibacterial therapy. Trends Biotechnol 36:875\u2013881","journal-title":"Trends Biotechnol"},{"key":"542_CR6","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1017\/S1431927616012514","volume":"22","author":"M Drab","year":"2016","unstructured":"Drab M, Krajniak J, Grzelakowski KP (2016) The new methodology and chemical contrast observation by use of the energy-selective back-scattered electron detector. Microsc Microanal 22:1369\u20131373","journal-title":"Microsc Microanal"},{"key":"542_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/168167a0","volume":"168","author":"M Dubois","year":"1951","unstructured":"Dubois M, Gilles K, Hamilton JK et al (1951) A colorimetric method for the determination of sugars. Nature 168:167","journal-title":"Nature"},{"key":"542_CR8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0021-9258(18)48372-X","volume":"267","author":"A Gamian","year":"1992","unstructured":"Gamian A, Beurret M, Michon F et al (1992a) Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis. J Biol Chem 267:922\u2013925","journal-title":"J Biol Chem"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1574-6968.1992.tb05012.x","volume":"4","author":"A Gamian","year":"1992","unstructured":"Gamian A, Romanowska A, Romanowska E (1992b) Immunochemical studies on sialic acid-containing lipopolysaccharides from enterobacterial species. FEMS Microbiol Immunol 4:323\u2013328","journal-title":"FEMS Microbiol Immunol"},{"key":"542_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","volume":"129","author":"I Goldschneider","year":"1969","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS (1969) Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 129:1327\u20131348","journal-title":"J Exp Med"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.2807\/esm.12.05.00707-en","volume":"12","author":"O Gryniewicz","year":"2007","unstructured":"Gryniewicz O, Kolbusz J, Rosinska M et al (2007) Epidemiology of meningococcal meningitis and changes in the surveillance system in Poland, 1970\u20132006. Euro Surveill 12:E7\u2013E8","journal-title":"Euro Surveill"},{"key":"542_CR12","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/IAI.61.5.1873-1880.1993","volume":"61","author":"XX Gu","year":"1993","unstructured":"Gu XX, Tsai CM (1993) Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugates. Infect Immun 61:1873\u20131880","journal-title":"Infect Immun"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1432-1033.1993.tb17971.x","volume":"214","author":"O Holst","year":"1993","unstructured":"Holst O, Broer W, Thomas-Oates JE et al (1993) Structural analysis of two oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant strain of Escherichia coli F515 (Re chemotype) expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur J Biochem 214:703\u2013710","journal-title":"Eur J Biochem"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1016\/j.vaccine.2008.09.041","volume":"26","author":"A Jakel","year":"2008","unstructured":"Jakel A, Plested JS, Hoe JC et al (2008) Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures. Vaccine 26:6655\u20136663","journal-title":"Vaccine"},{"key":"542_CR15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.127.3.1011","volume":"127","author":"HJ Jennings","year":"1981","unstructured":"Jennings HJ, Lugowski C (1981) Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J Immunol 127:1011\u20131018","journal-title":"J Immunol"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0008-6215(83)84020-8","volume":"121","author":"HJ Jennings","year":"1983","unstructured":"Jennings HJ, Johnson KG, Kenne L (1983a) The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis. Carbohydr Res 121:233\u2013241","journal-title":"Carbohydr Res"},{"key":"542_CR17","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/S0021-9258(18)33057-6","volume":"258","author":"HJ Jennings","year":"1983","unstructured":"Jennings HJ, Rosell KG, Katzenellenbogen E et al (1983b) Structural determination of the capsular polysaccharide antigen of type II group B Streptococcus. J Biol Chem 258:1793\u20131798","journal-title":"J Biol Chem"},{"key":"542_CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/IAI.43.1.407-412.1984","volume":"43","author":"HJ Jennings","year":"1984","unstructured":"Jennings HJ, Lugowski C, Ashton FE (1984) Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis. Infect Immun 43:407\u2013412","journal-title":"Infect Immun"},{"key":"542_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/BF00415511","volume":"53","author":"HJ Jennings","year":"1987","unstructured":"Jennings HJ, Beurret M, Gamian A et al (1987a) Structure and immunochemistry of meningococcal lipopolysaccharides. Antonie Van Leeuwenhoek 53:519\u2013522","journal-title":"Antonie Van Leeuwenhoek"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1084\/jem.165.4.1207","volume":"165","author":"HJ Jennings","year":"1987","unstructured":"Jennings HJ, Gamian A, Ashton FE (1987b) N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis. J Exp Med 165:1207\u20131211","journal-title":"J Exp Med"},{"key":"542_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1139\/m76-004","volume":"22","author":"KG Johnson","year":"1976","unstructured":"Johnson KG, Perry MB (1976) Improved techniques for the preparation of bacterial lipopolysaccharides. Can J Microbiol 22:29\u201334","journal-title":"Can J Microbiol"},{"key":"542_CR22","volume-title":"Immunochemistry in practice","author":"A Johnstone","year":"1982","unstructured":"Johnstone A, Thorpe R (1982) Immunochemistry in practice. Blackwell Scientific, Oxford"},{"key":"542_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0008-6215(96)00305-9","volume":"298","author":"G Kogan","year":"1997","unstructured":"Kogan G, Uhrin D, Brisson JR et al (1997) Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes. Carbohydr Res 298:191\u2013199","journal-title":"Carbohydr Res"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1046\/j.1365-2958.2002.02754.x","volume":"43","author":"FG Mackinnon","year":"2002","unstructured":"Mackinnon FG, Cox AD, Plested JS et al (2002) Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis. Mol Microbiol 43:931\u2013943","journal-title":"Mol Microbiol"},{"key":"542_CR25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/IAI.16.2.471-475.1977","volume":"16","author":"RE Mandrell","year":"1977","unstructured":"Mandrell RE, Zollinger WD (1977) Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition. Infect Immun 16:471\u2013475","journal-title":"Infect Immun"},{"key":"542_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1084\/jem.168.1.107","volume":"168","author":"RE Mandrell","year":"1988","unstructured":"Mandrell RE, Griffiss JM, Macher BA (1988) Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. Carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J Exp Med 168:107\u2013126","journal-title":"J Exp Med"},{"key":"542_CR27","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1128\/IAI.59.5.1690-1696.1991","volume":"59","author":"F Michon","year":"1991","unstructured":"Michon F, Chalifour R, Feldman R et al (1991) The alpha-l-(1\u20142)-trirhamnopyranoside epitope on the group-specific polysaccharide of group B streptococci. Infect Immun 59:1690\u20131696","journal-title":"Infect Immun"},{"key":"542_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0008-6215(02)00395-6","volume":"338","author":"M Mieszala","year":"2003","unstructured":"Mieszala M, Kogan G, Jennings HJ (2003) Conjugation of meningococcal lipooligosaccharides through their lipid A terminus conserves their inner epitopes and results in conjugate vaccines having improved immunological properties. Carbohydr Res 338:167\u2013175","journal-title":"Carbohydr Res"},{"key":"542_CR29","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1016\/j.carres.2003.08.014","volume":"338","author":"MA Monteiro","year":"2003","unstructured":"Monteiro MA, Fortuna-Nevin M, Farley J et al (2003) Phase-variation of the truncated lipo-oligosaccharide of Neisseria meningitidis NMB phosphoglucomutase isogenic mutant NMB-R6. Carbohydr Res 338:2905\u20132912","journal-title":"Carbohydr Res"},{"key":"542_CR30","doi-asserted-by":"crossref","first-page":"14146","DOI":"10.1016\/S0021-9258(19)85220-1","volume":"268","author":"V Pavliak","year":"1993","unstructured":"Pavliak V, Brisson JR, Michon F et al (1993) Structure of the sialylated L3 lipopolysaccharide of Neisseria meningitidis. J Biol Chem 268:14146\u201314152","journal-title":"J Biol Chem"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1056\/NEJM197709292971302","volume":"297","author":"H Peltola","year":"1977","unstructured":"Peltola H, Makela H, Kayhty H et al (1977) Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 297:686\u2013691","journal-title":"N Engl J Med"},{"key":"542_CR32","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1128\/IAI.67.10.5417-5426.1999","volume":"67","author":"JS Plested","year":"1999","unstructured":"Plested JS, Makepeace K, Jennings MP et al (1999) Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect Immun 67:5417\u20135426","journal-title":"Infect Immun"},{"key":"542_CR33","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1086\/368360","volume":"187","author":"JS Plested","year":"2003","unstructured":"Plested JS, Harris SL, Wright JC et al (2003) Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia. J Infect Dis 187:1223\u20131234","journal-title":"J Infect Dis"},{"key":"542_CR34","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1084\/jem.185.11.1929","volume":"185","author":"RA Pon","year":"1997","unstructured":"Pon RA, Lussier M, Yang QL et al (1997) N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J Exp Med 185:1929\u20131938","journal-title":"J Exp Med"},{"key":"542_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1086\/317646","volume":"183","author":"P Richmond","year":"2001","unstructured":"Richmond P, Borrow R, Goldblatt D et al (2001) Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis 183:160\u2013163","journal-title":"J Infect Dis"},{"key":"542_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","volume":"150","author":"PK Smith","year":"1985","unstructured":"Smith PK, Krohn RI, Hermanson GT et al (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76\u201385","journal-title":"Anal Biochem"},{"key":"542_CR37","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1016\/j.vaccine.2008.05.073","volume":"26","author":"CL Trotter","year":"2008","unstructured":"Trotter CL, McVernon J, Ramsay ME et al (2008) Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 26:4434\u20134445","journal-title":"Vaccine"},{"key":"542_CR38","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1128\/IAI.59.10.3604-3609.1991","volume":"59","author":"CM Tsai","year":"1991","unstructured":"Tsai CM, Civin CI (1991) Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lacto-N-neotetraose (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc). Infect Immun 59:3604\u20133609","journal-title":"Infect Immun"},{"key":"542_CR39","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1128\/IAI.59.10.3566-3573.1991","volume":"59","author":"AF Verheul","year":"1991","unstructured":"Verheul AF, Boons GJ, Van der Marel GA et al (1991) Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates. Infect Immun 59:3566\u20133573","journal-title":"Infect Immun"},{"key":"542_CR40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/MMBR.57.1.34-49.1993","volume":"57","author":"AF Verheul","year":"1993","unstructured":"Verheul AF, Snippe H, Poolman JT (1993) Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev 57:34\u201349","journal-title":"Microbiol Rev"},{"key":"542_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","volume":"126","author":"FA Wyle","year":"1972","unstructured":"Wyle FA, Artenstein MS, Brandt BL et al (1972) Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 126:514\u2013521","journal-title":"J Infect Dis"},{"key":"542_CR42","first-page":"63","volume":"55","author":"J Zabicka","year":"2001","unstructured":"Zabicka J, Zielinski A (2001) Meningitis and encephalitis in Poland in 1999. Przegl Epidemiol 55:63\u201373","journal-title":"Przegl Epidemiol"},{"key":"542_CR43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/IAI.18.2.424-433.1977","volume":"18","author":"WD Zollinger","year":"1977","unstructured":"Zollinger WD, Mandrell RE (1977) Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay. Infect Immun 18:424\u2013433","journal-title":"Infect Immun"},{"key":"542_CR44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/iai.28.2.451-458.1980","volume":"28","author":"WD Zollinger","year":"1980","unstructured":"Zollinger WD, Mandrell RE (1980) Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins. Infect Immun 28:451\u2013458","journal-title":"Infect Immun"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00542-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-019-00542-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-019-00542-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:15Z","timestamp":1704228555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-019-00542-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,27]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s00005-019-00542-9","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"type":"print","value":"0004-069X"},{"type":"electronic","value":"1661-4917"}],"subject":[],"published":{"date-parts":[[2019,4,27]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}